You are here: Industry Insights > COVID-19 vaccine

News List

Intravacc and EpiVax to develop Covid-19 vaccine candidate pharmaceutical-technology
June 04, 2020
Dutch research and development vaccine institute Intravacc has partnered with US-based biotechnology firm EpiVax to advance a Covid-19 vaccine candidate.
Baylor College and Texas Children’s to advance Covid-19 vaccine pharmaceutical-technology
June 04, 2020
Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their alliance with Infectious Disease Research Institute (IDRI) to accelerate the development of a Covid-19 vaccine candidate.
Lonza sets new goal to make Moderna COVID-19 vaccine ingredients expresspharma
June 04, 2020
Moderna, which enlisted Lonza in May in a 10-year manufacturing contract, is racing with 100-plus other vaccine projects, having last week dosed initial participants in a 600-patient study.
Emergent to assist in production of US COVID-19 vaccine candidates europeanpharmaceuticalreview
June 03, 2020
The company announces it has been task ordered by BARDA to assist in the US government’s efforts to deliver COVID-19 vaccines.
MilliporeSigma and Baylor Enter COVID-19 Vax Pact contractpharma
June 03, 2020
Will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates.
Emergent gets $628m Covid-19 vaccine manufacturing contract pharmaceutical-technology
June 03, 2020
Emergent BioSolutions has secured a $628m contract from the US Biomedical Advanced Research and Development Authority (BARDA) for domestic manufacturing of Covid-19 vaccine candidates.
CDMO delivers 4000 doses of COVID-19 vaccine candidate for Phase II/III trial europeanpharmaceuticalreview
June 01, 2020
Advent announced it has manufactured and delivered the first 4000 doses of the AZD1222 vaccine candidate for the University of Oxford clinical trial.
GSK plans to produce one billion pandemic vaccine adjuvant doses pharmaceutical-technology
June 01, 2020
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system next year to support adjuvanted Covid-19 vaccine candidates development.
Chimeron Bio and NCBID to develop Covid-19 vaccine pharmaceutical-technology
June 01, 2020
RNA therapeutics firm Chimeron Bio has collaborated with George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID) to develop a Covid-19 vaccine candidate.
Novavax buys Praha Vaccines for Covid-19 vaccine manufacturing pharmaceutical-technology
May 29, 2020
Biotechnology firm Novavax has acquired Czech Republic-based Praha Vaccines for approximately $167m to support the manufacture of its Covid-19 vaccine candidate, NVX‑CoV2373.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page